Fibroblast Growth Factor 21 and 23 as Biomarkers for Early Stage Diabetic Nephropathy in Type 2 Diabetic Patients

Assessment of Serum Fibroblast Growth factor 19 and Des-gamma Carboxy Prothrombin for Early Diagnosis of Hepatocellular Carcinoma

Serum Levels of Angiopoietin-2 and C-Reactive Protein in Chronic Myeloid Leukaemia Patients: Relation to Different Phases of the Disease

Abnormalities Of Chromosome 17 In Patients With Myeloid Malignancies.

Prognostic Role of Tetraspanin CD81 in Patients with Acute Myeloid Leukemia

ROLE OF CD200 IN ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA

The role of CD58 and CD38 in evaluation of minimal residual disease in childhood B-acute lymphoblastic leukemia

Fibroblast Growth Factor 21 as a possible metabolic marker of diabetic nephropathy in Type 2 diabetic patients

Morphological and functional characteristics of long-term peripheral blood culture in chronic myelogenous leukemia

Level of Basic Fibroblast Growth Factor in Breast Cancer Patients